Advertisement

Most Recent

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

image: Mitochondrial Enzyme Detailed

Mitochondrial Enzyme Detailed

By | January 9, 2015

Researchers reveal clues regarding how an ancient mitochondrial enzyme helps maintain healthy cells across the tree of life.

0 Comments

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

0 Comments

image: Two Chemists Knighted

Two Chemists Knighted

By | January 2, 2015

Researchers who contributed to the development of Viagra and produced “greener” solvents, respectively, achieved knight status from the Queen of England.

0 Comments

image: Taming Bushmeat

Taming Bushmeat

By | January 1, 2015

Chinese farmers’ efforts at rearing wild animals may benefit conservation and reduce human health risks.

1 Comment

image: Stress Fractures

Stress Fractures

By | January 1, 2015

Social adversity shapes humans’ immune systems—and probably their susceptibility to disease—by altering the expression of large groups of genes.

6 Comments

image: Bats Make a Comeback

Bats Make a Comeback

By | December 22, 2014

Citizen-scientist data obtained through the U.K.’s National Bat Monitoring Programme show that populations of 10 bat species have stabilized or are growing.

0 Comments

image: Reprogramming Redux

Reprogramming Redux

By | December 18, 2014

Can mechanical forces alone be manipulated to create stem-like cells?

1 Comment

image: Honeybee Compound for Hair Loss?

Honeybee Compound for Hair Loss?

By | December 11, 2014

Propolis, a natural product used by honeybees to repair their hives, stimulates hair growth in shaved mice.

1 Comment

image: Layoffs, Restructuring at GSK

Layoffs, Restructuring at GSK

By | December 4, 2014

GlaxoSmithKline is eliminating 900 US jobs—most in R&D.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist